Helicobacter pylori-negative ulcer disease

Journal of Gastroenterology

Volumn 35, Issue SUPPL. 12, 2000, Pages 47-50

  McColl, Kenneth E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Aetiology; Helicobacter pylori; Helicobacter pylori negative; Pathophysiology; Ulcer disease

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR; SUCRALFATE;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; CROHN DISEASE; DUODENUM PH; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PATHOGENESIS; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; STOMACH ACID SECRETION; ZOLLINGER ELLISON SYNDROME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC ACIDITY DETERMINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0034099124     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-41.
2. O'Riordan T, Mathai E, Tobin E, McKenna D, Keane C, Sweeney E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990;31:999-1002.
3. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
4. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992;116:705-8.
5. Axon ATR, O'Morain CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RPH, et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ 1997;314:565-8.
6. Borody T, Noonan S, Cole P, Hyland L, Morgan A, Lenne J, Moore-Jones D, Brandl S. Duodenal ulcer recurrence in patients remaining C. pylori (CP): negative long term post-eradication. Gastroenterology 1989;96:A52.
7. Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995;41:5-7.
8. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995;41:1-4.
9. McColl KEL, El-Nujumi AM, Chittajallu RS, Dahill SW, Dorrian CA, El-Omar E, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993;34:762-8.
10. Hyvarinen H, Salmenkyla S, Sipponen P. Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs. Digestion 1996;57:305-9.
11. Maher W, Jyotheeswaran S, Potter G, Shah A, Malkin M, Joseph D, et al. An epidemiological study of peptic ulcer disease patients in greater Rochester, New York. Gastroenterology 1997;112: A206.
12. Cohen ME, Culpepper-Morgan JA, Galusha DH, Williams J. Prevalence of Helicobactor pylori in elderly patents hospitalized for peptic ulcer disease. Gastroenterology 1999;116:A51.
13. McDonagh TA, Woodward M, Morrison CE, McMurray JJV, Tunstall-Pedoe H, Lowe GDO, et al. Helicobacter pylori infection and coronary heart disease in the north Glasgow MONICA population. Eur Heart J 1997;18:1257-60.
14. Graham DY, Malaty HM, Evans DG, Evans D Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 1991;100:1495-501.
15. 14C] urea breath test. Eur J Gastroenterol Hepatol 1998;10:759-64.
16. Graham DY, Genta R, Evans D, Reddy R, Clarridge JE, Olson CA, et al. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 1996;91:2120-4.
17. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim ON, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-16.
18. 14C-urea breath test. Am J Gastroenterol 1996;91:89-92.
19. 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol 1997;92:446-50.
20. Verdu E, Viani F, Armstrong D, Fraser R, Siegrist HH, Pignatelli B, et al. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites and N-nitroso compounds. Gut 1994;35:455-60.
21. Chey WD. Proton pump inhibitors and the urea breath test: how long is long enough? Am J Gastroenterol 1997;92:720-1.
22. Graham DY. Proton pump inhibitors and the urea breath test: 4 weeks after therapy is best. Am J Gastroenterol 1997;92:721.
23. Dickey W, Kenny BD, McConnell JB. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther 1996;10:289-93.
24. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
25. Borody TJ, George LL, Brandi S, Andrews P, Ostapowicz N, Hyland L, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991;86:1154-7.
26. Nensey YW, Schubert TT, Bologna SD, Ma CK. Helicobhacter pylori-negative duodenal ulcer. Am J Med 1991;91:15-18.
27. Di Battista R, Bierti L, Benassi R, et al. Prevalence and risk factors in Helicobacter pyori peptic ulcer in an area of northern Italy. Gastroenterology 1997;112:A102.
28. Hirschowitz BI. Intractable peptic ulceration due to aspirin abuse in patients who have not had gastric surgery. Gastroenterology 1997;112:A962.
29. Fich A, Talley NJ, Shorter RG, Phillips SF, Zollinger-Ellison syndrome: relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion. Dig Dis Sci 1991;36:10-14.
30. McColl KEL, El-Omar E, Gillen D. Pathophysiologic aspects of peptic ulcer disease. JAMA 1998;14:8-12.
31. Harris AW, Gummett PA, Phull PS, Jacyna MR, Misiewicz JJ, Baron JH. Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output. Aliment Pharmacol 1997;11:331-4.
32. Verdu EF, Armstrong D, Fraser R, Viani F, Idstrom J-P, Cederberg C, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995;36: 539-43.
33. Verdu EF, Armstrong D, Idstrom J-P, Labenz J, Stolte M, Dorta G, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995;37: 743-8.
34. Gillen D, Wirz AA, Neithercut WD, Ardill JES, McColl KEL. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 1999;44:468-75.
35. Banerjee S, El-Omar E, Mowat A, Ardill JES, Park RHR, Watson W, et al. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology 1996;110:717-24.